Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | METAP2 | P50579 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | GFER | P55789 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17463276 | 0.94 | KDM4E (0.40) | KDM4EATML3MBTL1CYP1A2METAP2 | |
| SCHEMBL17463231 | 0.90 | KDM4E (0.40) | KDM4EATML3MBTL1CYP1A2METAP2 | |
| SCHEMBL17463223 | 0.90 | KDM4E (0.46) | KDM4EATML3MBTL1MAPTGFER | |
| SCHEMBL17463278 | 0.89 | L3MBTL1 (0.45) | KDM4EATML3MBTL1CYP1A2METAP2 | |
| SCHEMBL17463202 | 0.89 | L3MBTL1 (0.47) | KDM4EATML3MBTL1CYP1A2METAP2 | |
| SCHEMBL17463401 | 0.88 | L3MBTL1 (0.44) | KDM4EATML3MBTL1CYP1A2METAP2 | |
| SCHEMBL17463279 | 0.87 | L3MBTL1 (0.46) | KDM4EATML3MBTL1CYP1A2METAP2 | |
| SCHEMBL25673105 | 0.86 | KDM4E (0.45) | KDM4EATML3MBTL1MAPTNPSR1 | |
| SCHEMBL25673106 | 0.86 | KDM4E (0.45) | KDM4EATML3MBTL1MAPTNPSR1 | |
| SCHEMBL12721957 | 0.85 | KDM4E (0.46) | KDM4EATML3MBTL1GFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160028030-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2016-01-28 | — | — | US | disclosed |
| US-20160028030-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2016-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160028030-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNE2, CCNE1 | KDM4E 1882/4885ATM 1164/4885L3MBTL1 863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.